Dental biomaterials include a broad range of substances designed for use in dental applications such as restorations, implants, prosthetics, and orthodontics. These materials encompass ceramics, polymers, metals, composites, and natural biomaterials, with each offering distinct benefits in durability, biocompatibility, and aesthetics. The market for dental biomaterials is driven by increasing demand for cosmetic and restorative dentistry, advancements in material science, and the adoption of digital dentistry solutions like CAD/CAM and 3D printing. Stringent regulatory compliance, price sensitivity, and raw material availability remain critical factors shaping market growth. The global dental biomaterials market is expected to exhibit steady growth through 2035, fostered by technological innovation and enhanced access to dental care worldwide.

Ceramics dominate the dental biomaterials market in 2025, capturing the highest share due to their excellent biocompatibility and aesthetic qualities for crowns and bridges. Metallic biomaterials retain significant usage in dental implants given their durability, while polymeric biomaterials are increasingly popular in temporary restorations and orthodontic devices. Composite and natural biomaterials are gaining traction in minimally invasive procedures and tissue engineering owing to favorable mechanical and regenerative properties.

In 2025, implantology leads dental biomaterials applications with the largest share, reflecting an increasing trend in dental implants and tooth replacement procedures globally. Prosthodontics holds a strong position due to the growing need for crowns, bridges, and dentures among aging populations. Orthodontics, while smaller in share, is advancing rapidly, especially with the integration of polymeric and ceramic biomaterials for clear aligners and brackets.

The global dental biomaterials market revenue is projected to grow robustly from $6,200 Million in 2020 to $13,530 Million by 2035. This sustained growth is underpinned by technological advances, higher implant adoption, and broader dental therapy applications, with YOY growth rates peaking in the mid-2020s and steadying towards 2035.

Year-on-year (YoY) growth rates reflect robust momentum between 2020 and 2035, with a peak observed in the period 2025-2030 at 8%. Growth gradually moderates but remains positive through 2035, as adoption stabilizes and the market matures, making dental biomaterials a resilient sector in the evolving oral healthcare landscape.

North America is set to maintain market leadership in 2025, underpinned by rapid adoption of advanced dental technologies and a high prevalence of dental procedures. Europe remains a close second, driven by an established dental care infrastructure. The Asia-Pacific region is emerging strongly, with increased healthcare spending and growing awareness about dental implants and restorations.

Dentsply Sirona, Straumann Holding AG, and Danaher Corporation are positioned as the top players, collectively accounting for nearly 40% of the market. Their global reach, well-established portfolios, and cutting-edge product launches ensure sustained leadership. Other major contributors include Henry Schein, Inc., 3M Company, and Zimmer Biomet, who offer broad geographical presence and innovative biomaterials.

Dental clinics take up the largest share of buyers, followed by hospitals and group practices. The growing number of private clinics and specialized dental centers contributes heavily to overall demand. Academic institutions and research centers account for a smaller share, mainly focused on R&D and training with advanced biomaterials.